<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25754930</PMID><DateCompleted><Year>2016</Year><Month>04</Month><Day>01</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1582-4934</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>5</Issue><PubDate><Year>2015</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of cellular and molecular medicine</Title><ISOAbbreviation>J Cell Mol Med</ISOAbbreviation></Journal><ArticleTitle>Up-regulation of galectin-9 induces cell migration in human dendritic cells infected with dengue virus.</ArticleTitle><Pagination><StartPage>1065</StartPage><EndPage>1076</EndPage><MedlinePgn>1065-76</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jcmm.12500</ELocationID><Abstract><AbstractText>Galectin-9 (Gal-9) exerts immunosuppressive effects by inducing apoptosis in T cells that produce interferon-&#x3b3; and interleukin (IL)-17. However, Gal-9 can be pro-inflammatory in lipopolysaccharide-stimulated monocytes. Using microarray analysis, we observed that Gal-9 was up-regulated in human dendritic cells (DCs) after dengue virus (DV) infection. The investigation into the immunomodulatory effects and mechanisms of Gal-9 in DCs exposed to DV revealed that DV infection specifically increased mRNA and protein levels of Gal-9 but not those of Gal-1 or Gal-3. Blocking p38, but not c-Jun N-terminal kinase or extracellular signal-regulated kinase (ERK), inhibited DV-induced expression of Gal-9. Reduction in Gal-9 by small interference RNA treatment suppressed DV-stimulated migration of DCs towards the chemoattractants CCL19 and CCL21. In addition, DV-induced IL-12p40 production was reduced after knockdown of Gal-9 in DCs. Furthermore, Gal-9 deficiency suppressed DV-induced activation of nuclear factor-&#x3ba;B. Inhibition of DV-induced DC migration under conditions of Gal-9 deficiency was mediated through suppressing ERK activation but not by regulating the expression of CCR7, the receptor for CCL19 and CCL21. Both the reduction in IL-12 production and the suppression of ERK activity might account for the inhibition of DV-induced DC migration after knockdown of Gal-9. In summary, this study reveals the roles of Gal-9 in DV-induced migration of DCs. The findings indicate that Gal-9 might be a therapeutic target for preventing immunopathogenesis induced by DV infection.</AbstractText><CopyrightInformation>&#xa9; 2015 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley &amp; Sons Ltd and Foundation for Cellular and Molecular Medicine.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>Yu-Lin</ForeName><Initials>YL</Initials><AffiliationInfo><Affiliation>Graduate Institute of Medical Science, National Defense Medical Center, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Mei-Yi</ForeName><Initials>MY</Initials></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Ling-Jun</ForeName><Initials>LJ</Initials></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Chuan-Yueh</ForeName><Initials>CY</Initials></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Jenn-Haung</ForeName><Initials>JH</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>03</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Cell Mol Med</MedlineTA><NlmUniqueID>101083777</NlmUniqueID><ISSNLinking>1582-1838</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054415">Chemokine CCL19</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054421">Chemokine CCL21</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D037161">Galectins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007093">Imidazoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053762">Interleukin-12 Subunit p40</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C105032">LGALS9 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011725">Pyridines</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.24</RegistryNumber><NameOfSubstance UI="D048049">Extracellular Signal-Regulated MAP Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.24</RegistryNumber><NameOfSubstance UI="D048051">p38 Mitogen-Activated Protein Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>OU13V1EYWQ</RegistryNumber><NameOfSubstance UI="C093642">SB 203580</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002465" MajorTopicYN="Y">Cell Movement</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054415" MajorTopicYN="N">Chemokine CCL19</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054421" MajorTopicYN="N">Chemokine CCL21</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003713" MajorTopicYN="N">Dendritic Cells</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000254" MajorTopicYN="Y">growth &amp; development</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004789" MajorTopicYN="N">Enzyme Activation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D048049" MajorTopicYN="N">Extracellular Signal-Regulated MAP Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D037161" MajorTopicYN="N">Galectins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="N">Host-Pathogen Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007093" MajorTopicYN="N">Imidazoles</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053762" MajorTopicYN="N">Interleukin-12 Subunit p40</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011725" MajorTopicYN="N">Pyridines</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034622" MajorTopicYN="N">RNA Interference</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="Y">Up-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D048051" MajorTopicYN="N">p38 Mitogen-Activated Protein Kinases</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cell migration</Keyword><Keyword MajorTopicYN="N">dendritic cells</Keyword><Keyword MajorTopicYN="N">dengue virus</Keyword><Keyword MajorTopicYN="N">galectin-9</Keyword><Keyword MajorTopicYN="N">immune response</Keyword><Keyword MajorTopicYN="N">mitogen-activated protein kinase</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25754930</ArticleId><ArticleId IdType="pmc">PMC4420608</ArticleId><ArticleId IdType="doi">10.1111/jcmm.12500</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hirabayashi J, Kasai K. The family of metazoan metal-independent beta-galactoside-binding lectins: structure, function and molecular evolution. Glycobiology. 1993;3:297&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pubmed">8400545</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato S, Ouellet M, St-Pierre C, et al. Glycans, galectins, and HIV-1 infection. Ann N Y Acad Sci. 2012;1253:133&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">22524424</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundblad V, Croci DO, Rabinovich GA. Regulated expression of galectin-3, a multifunctional glycan-binding protein, in haematopoietic and non-haematopoietic tissues. Histol Histopath. 2011;26:247&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">21154238</ArticleId></ArticleIdList></Reference><Reference><Citation>Imbeault M, Lodge R, Ouellet M, et al. Efficient magnetic bead-based separation of HIV-1-infected cells using an improved reporter virus system reveals that p53 up-regulation occurs exclusively in the virus-expressing cell population. Virology. 2009;393:160&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">19692106</ArticleId></ArticleIdList></Reference><Reference><Citation>Nebbia G, Peppa D, Schurich A, et al. Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection. PLoS ONE. 2012;7:e47648.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3480425</ArticleId><ArticleId IdType="pubmed">23112829</ArticleId></ArticleIdList></Reference><Reference><Citation>Kared H, Fabre T, Bedard N, et al. Galectin-9 and IL-21 mediate cross-regulation between Th17 and Treg cells during acute hepatitis C. PLoS Pathog. 2013;9:e1003422.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3688567</ArticleId><ArticleId IdType="pubmed">23818845</ArticleId></ArticleIdList></Reference><Reference><Citation>Seki M, Sakata KM, Oomizu S, et al. Beneficial effect of galectin 9 on rheumatoid arthritis by induction of apoptosis of synovial fibroblasts. Arthritis Rheum. 2007;56:3968&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">18050192</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabinovich GA, Toscano MA, Jackson SS, et al. Functions of cell surface galectin-glycoprotein lattices. Curr Opin Struct Biol. 2007;17:513&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2100406</ArticleId><ArticleId IdType="pubmed">17950594</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabatos CA, Chakravarti S, Cha E, et al. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat Immunol. 2003;4:1102&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">14556006</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu C, Anderson AC, Schubart A, et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol. 2005;6:1245&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">16286920</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Manzanet R, DeKruyff R, Kuchroo VK, et al. The costimulatory role of TIM molecules. Immunol Rev. 2009;229:259&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3217781</ArticleId><ArticleId IdType="pubmed">19426227</ArticleId></ArticleIdList></Reference><Reference><Citation>Seki M, Oomizu S, Sakata KM, et al. Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin Immunol. 2008;127:78&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">18282810</ArticleId></ArticleIdList></Reference><Reference><Citation>Arikawa T, Saita N, Oomizu S, et al. Galectin-9 expands immunosuppressive macrophages to ameliorate T-cell-mediated lung inflammation. Eur J Immunol. 2010;40:548&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">19902429</ArticleId></ArticleIdList></Reference><Reference><Citation>Dardalhon V, Anderson AC, Karman J, et al. Tim-3/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells. J Immunol. 2010;185:1383&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2925247</ArticleId><ArticleId IdType="pubmed">20574007</ArticleId></ArticleIdList></Reference><Reference><Citation>Kojima K, Arikawa T, Saita N, et al. Galectin-9 attenuates acute lung injury by expanding CD14- plasmacytoid dendritic cell-like macrophages. Am J Respir Crit Care Med. 2011;184:328&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">21562126</ArticleId></ArticleIdList></Reference><Reference><Citation>Golden-Mason L, McMahan RH, Strong M, et al. Galectin-9 functionally impairs natural killer cells in humans and mice. J Virol. 2013;87:4835&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3624298</ArticleId><ArticleId IdType="pubmed">23408620</ArticleId></ArticleIdList></Reference><Reference><Citation>Moritoki M, Kadowaki T, Niki T, et al. Galectin-9 ameliorates clinical severity of MRL/lpr lupus-prone mice by inducing plasma cell apoptosis independently of Tim-3. PLoS ONE. 2013;8:e60807.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3621869</ArticleId><ArticleId IdType="pubmed">23585851</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuura A, Tsukada J, Mizobe T, et al. Intracellular galectin-9 activates inflammatory cytokines in monocytes. Genes Cells. 2009;14:511&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">19335620</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayaraman P, Sada-Ovalle I, Beladi S, et al. Tim3 binding to galectin-9 stimulates antimicrobial immunity. J Exp Med. 2010;207:2343&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2964580</ArticleId><ArticleId IdType="pubmed">20937702</ArticleId></ArticleIdList></Reference><Reference><Citation>Gieseke F, Kruchen A, Tzaribachev N, et al. Proinflammatory stimuli induce galectin-9 in human mesenchymal stromal cells to suppress T-cell proliferation. Eur J Immunol. 2013;43:2741&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">23817958</ArticleId></ArticleIdList></Reference><Reference><Citation>Su EW, Bi S, Kane LP. Galectin-9 regulates T helper cell function independently of Tim-3. Glycobiology. 2011;21:1258&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3167474</ArticleId><ArticleId IdType="pubmed">21187321</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho LJ, Wang JJ, Shaio MF, et al. Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J Immunol. 2001;166:1499&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pubmed">11160189</ArticleId></ArticleIdList></Reference><Reference><Citation>Warke RV, Xhaja K, Martin KJ, et al. Dengue virus induces novel changes in gene expression of human umbilical vein endothelial cells. J Virol. 2003;77:11822&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC229255</ArticleId><ArticleId IdType="pubmed">14557666</ArticleId></ArticleIdList></Reference><Reference><Citation>Chagan-Yasutan H, Ndhlovu LC, Lacuesta TL, et al. Galectin-9 plasma levels reflect adverse hematological and immunological features in acute dengue virus infection. J Clin Virol. 2013;58:635&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3880569</ArticleId><ArticleId IdType="pubmed">24239423</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho LJ, Hung LF, Weng CY, et al. Dengue virus type 2 antagonizes IFN-alpha but not IFN-gamma antiviral effect via down-regulating Tyk2-STAT signaling in the human dendritic cell. J Immunol. 2005;174:8163&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">15944325</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu YL, Shi SF, Wu WL, et al. Protective roles of interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) in dengue virus infection of human lung epithelial cells. PLoS ONE. 2013;8:e79518.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3817122</ArticleId><ArticleId IdType="pubmed">24223959</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu WL, Ho LJ, Chang DM, et al. Triggering of DC migration by dengue virus stimulation of COX-2-dependent signaling cascades in vitro highlights the significance of these cascades beyond inflammation. Eur J Immunol. 2009;39:3413&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">19862774</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson AC, Anderson DE, Bregoli L, et al. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science. 2007;318:1141&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">18006747</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai YT, Chang SY, Lee CN, et al. Human TLR3 recognizes dengue virus and modulates viral replication in vitro. Cell Microbiol. 2009;11:604&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">19134117</ArticleId></ArticleIdList></Reference><Reference><Citation>Klibi J, Niki T, Riedel A, et al. Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells. Blood. 2009;113:1957&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">19005181</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai SY, Nakagawa R, Itoh A, et al. Galectin-9 induces maturation of human monocyte-derived dendritic cells. J Immunol. 2005;175:2974&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">16116184</ArticleId></ArticleIdList></Reference><Reference><Citation>Khader SA, Partida-Sanchez S, Bell G, et al. Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection. J Exp Med. 2006;203:1805&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2118335</ArticleId><ArticleId IdType="pubmed">16818672</ArticleId></ArticleIdList></Reference><Reference><Citation>McSharry BP, Forbes SK, Cao JZ, et al. Human cytomegalovirus upregulates expression of the lectin galectin 9 via induction of beta interferon. J Virol. 2014;88:10990&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4178876</ArticleId><ArticleId IdType="pubmed">25008927</ArticleId></ArticleIdList></Reference><Reference><Citation>Katoh S, Ikeda M, Shimizu H, et al. Increased levels of plasma galectin-9 in patients with influenza virus infection. Tohoku J Exp Med. 2014;232:263&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">24695077</ArticleId></ArticleIdList></Reference><Reference><Citation>Jost S, Moreno-Nieves UY, Garcia-Beltran WF, et al. Dysregulated Tim-3 expression on natural killer cells is associated with increased Galectin-9 levels in HIV-1 infection. Retrovirology. 2013;10:74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3750478</ArticleId><ArticleId IdType="pubmed">23866914</ArticleId></ArticleIdList></Reference><Reference><Citation>Mengshol JA, Golden-Mason L, Arikawa T, et al. A crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infection. PLoS ONE. 2010;5:e9504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2831996</ArticleId><ArticleId IdType="pubmed">20209097</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi S, Hong PW, Lee B, et al. Galectin-9 binding to cell surface protein disulfide isomerase regulates the redox environment to enhance T-cell migration and HIV entry. Proc Natl Acad Sci USA. 2011;108:10650&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3127870</ArticleId><ArticleId IdType="pubmed">21670307</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagahara K, Arikawa T, Oomizu S, et al. Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions. J Immunol. 2008;181:7660&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5886706</ArticleId><ArticleId IdType="pubmed">19017954</ArticleId></ArticleIdList></Reference><Reference><Citation>Slight SR, Lin Y, Messmer M, et al. Francisella tularensis LVS-induced Interleukin-12 p40 cytokine production mediates dendritic cell migration through IL-12 Receptor beta1. Cytokine. 2011;55:372&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3148298</ArticleId><ArticleId IdType="pubmed">21669537</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohler T, Reizis B, Johnson RS, et al. Influence of hypoxia-inducible factor 1alpha on dendritic cell differentiation and migration. Eur J Immunol. 2012;42:1226&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6592818</ArticleId><ArticleId IdType="pubmed">22539295</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung ID, Lee JS, Kim YJ, et al. Sphingosine kinase inhibitor suppresses dendritic cell migration by regulating chemokine receptor expression and impairing p38 mitogen-activated protein kinase. Immunology. 2007;121:533&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2265963</ArticleId><ArticleId IdType="pubmed">17428311</ArticleId></ArticleIdList></Reference><Reference><Citation>Humrich JY, Thumann P, Greiner S, et al. Vaccinia virus impairs directional migration and chemokine receptor switch of human dendritic cells. Eur J Immunol. 2007;37:954&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">17357104</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodward AM, Mauris J, Argueso P. Binding of transmembrane mucins to galectin-3 limits herpesvirus 1 infection of human corneal keratinocytes. J Virol. 2013;87:5841&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3648170</ArticleId><ArticleId IdType="pubmed">23487460</ArticleId></ArticleIdList></Reference><Reference><Citation>St-Pierre C, Manya H, Ouellet M, et al. Host-soluble galectin-1 promotes HIV-1 replication through a direct interaction with glycans of viral gp120 and host CD4. J Virol. 2011;85:11742&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3209312</ArticleId><ArticleId IdType="pubmed">21880749</ArticleId></ArticleIdList></Reference><Reference><Citation>Nobumoto A, Nagahara K, Oomizu S, et al. Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices. Glycobiology. 2008;18:735&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">18579572</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisz OA, Rodriguez-Boulan E. Apical trafficking in epithelial cells: signals, clusters and motors. J Cell Sci. 2009;122:4253&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2779128</ArticleId><ArticleId IdType="pubmed">19923269</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo D, Costa SA, Ihrke G, et al. Sialylation of N-linked glycans mediates apical delivery of endolyn in MDCK cells via a galectin-9-dependent mechanism. Mol Biol Cell. 2012;23:3636&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3442411</ArticleId><ArticleId IdType="pubmed">22855528</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>